
Does Google health have a place in practice management

Does Google health have a place in practice management

With BluePeak? - blue laser autofluorescence you can noninvasively view the health of the RPE, providing a functional map of RPEphotoreceptor metabolism. BluePeak is available for all SPECTRALIS models.

Clinician-scientist also trained ophthalmic leaders

FD-OCT adds accuracy to diagnostic assessment with measurement of GCC

As a committed pioneer in the field of ophthalmology, Carl Zeiss Meditec supplies innovative technologiesand application-oriented solutions which enable doctors to improve the quality of life of their patients.

Femtosecond laser use on the up for flap creation is just one trend

Non-incisional treatment preserves the biomechanical integrity of the cornea

A small case study looking at cornea temperature rise during laser treatment using a new 'Intelligent Thermal Effect Control'

Physicians must be aware of options, know how to use different categories of viscoelastic

Haag-Streit and our sister companies – Reliance, Moeller–Wedel, Clement Clarke and John Weiss – are leading players in ophthalmology today – as they have been for more than 150 years.

Gene replacement, enhanced genetic testing, clinical trial s show promising future

For nearly two centuries, Moria has been a manufacturer of sophisticated and high quality ophthalmic surgical instrumentation and equipment.

Micro incision surgery for anterior and posterior procedures is featured at the Oertli® booth.

A study of scanning laser ophthalmoscope devices

Medical therapies are effective, but expensive too

Since introducing the first Laser photocoagulator to ophthalmology in 1970, Lumenis Vision has focused on providing ophthalmologists with innovative laser therapies to preserve and improve the sight of patients worldwide.

According to its press release GBI Research has found that the global ophthalmology market will grow at a moderate rate due to the impact of generic erosion in some markets such as glaucoma and allergic conjunctivitis.

For almost 60 years, the Geuder Group has been developing, manufacturing and distributing ophthalmo-surgical instruments, systems and vitreoretinal liquids.

STAAR Surgical has received CE mark approval for product improvements to its Visian Implantable Collamer Lens (ICL). It also received approval for a Hyperopic Toric ICL which is designed for patients with both hyperopia, as well as astigmatism.

An intact tear film and a good oxygen supply for the cornea are indispensable for contact lens wearing comfort. With the Keratograph TF-Scan software you can analyze the tear film non-invasively.

Experience the revolution in cross linking at booth 15 B 50 where bon Optic will be showing the new Ricrolin TE from the company Sooft.

The Ophthalmology TImes Europe team is looking forward to meeting many readers and customers at the Congress and to bringing you coverage of the event and new developments emerging from it.

Mapping epithelial thickness in patients with abnormal topography may rule out keratoconus

Santen is a Japanese R&D focused pharmaceutical company specializing in the development and manufacturing of ophthalmic products.

Recent research by the Optical Express Group says it has revealed that of 32,000 clients surveyed following treatment in 2009, 89 per cent achieved 20/16 vision or better.

According to Novartis the independent DRCR.net study data being presented for the first time in the UK, show that ranibizumab is significantly more effective than laser treatment, the current standard of care, at treating visual impairment due to diabetic macular oedema (DMO).

A small German study of light adjustable lenses (LALs) implanted in 10 eyes in 7 patients has produced positive results, according to the lens's manufacturer, Calhoun Vision.

In a recent press statement Allergan Ltd announced that the Committee for Medicinal Products for Human Use (CHMP) has recommended granting a Marketing Authorisation for OZURDEX (dexamethasone drug delivery system [DEX-DDS]) in the 27 member states of the European Union.

A new type of procedure for correcting short-sightedness could be safer than laser eye surgery, according to a new Cochrane Systematic Review. The study also shows that patients prefer the new procedure, despite there being little difference between the two in terms of improving vision.
